09.10.2013 Views

Dermatologic Differential Diagnosis.pdf. - Famona Site

Dermatologic Differential Diagnosis.pdf. - Famona Site

Dermatologic Differential Diagnosis.pdf. - Famona Site

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

510 A CLINICIAN’S GUIDE TO DERMATOLOGIC DIFFERENTIAL DIAGNOSIS, VOLUME 1<br />

Enalapril – photolichenoid eruption Dermatology 187:80, 1993<br />

Enoxacin Photodermatol Photoimmunol Photomed 9:159–161,<br />

1993; photoallergy Photodermatol 6:57–59, 1989<br />

Ethionamide – pellagrous dermatitis JAAD 46:597–599, 2002<br />

Etoposide and cyclophosphamide – ultraviolet recall Clin Exp<br />

Dermatol 18:452–453, 1993<br />

Etretinate – UVA/?UVB<br />

Farmorubicin – erythematobullous photoeruption Contact<br />

Dermatitis 30:303–304, 1994<br />

Felodipine-induced photodistributed facial telangiectasia<br />

JAAD 45:323–324, 2001<br />

Fenofibrate JAAD 35:775–777, 1996; Photodermatol<br />

Photoimmunol Photomed 7:136–137, 1990<br />

Fibric acid derivatives – UVA/UVB JAAD 27:204–208, 1992<br />

Fleroxacin Clin Exp Dermatol 21:46–47, 1996<br />

Fluorescein dye, IV Retina 20:370–373, 2000; Photodermatol<br />

Photoimmunol Photomed 11:178–179, 1995<br />

Fluoroqinolones – lomafloxacin (UVA/?UVB) AD 130:808–809,<br />

1994; ofloxacin Int J Dermatol 32:413–416, 1993; ciprofloxacin<br />

BJD 123:9–20, 1990; norfloxacin J Dermatol Sci 18:1–10, 1998;<br />

Contact Derm 26:5–10, 1992; AD 130:261, 1994; sparfloxacin<br />

JAAD 38:945–949, 1998; drug-induced porphyria cutanea tarda<br />

due to fluoroquinolone Dermatol Clinic 4:291–296, 1986<br />

5-fluorocytosine JAAD 8:229–235, 1983<br />

5-fluorouracil – phototoxicity JAAD 40:367–398, 1999;<br />

JAAD 25:905–908, 1991; Cutis 22:609–610, 1978;<br />

photo-distributed hyperpigmentation Bolognia p.978, 2003;<br />

topical JAAD 4:633–649, 1981<br />

Fluoxetine J Clin Psychiatry 56:486, 1995<br />

Flutamide Photodermatol Photoimmunol Photomed<br />

12:216–218, 1996; Eur J Dermatol 8:427–429, 1998;<br />

with residual vitiligo Contact Dermatitis 38:68–70, 1998<br />

Fluvoxamine Australas J Dermatol 37:62, 1996<br />

Furosemide – phototoxic blisters BJD 94:495–499, 1976<br />

Glyburide Photodermatol 5:42–45, 1988<br />

Griseofulvin Photodermatol 5:272–274, 1988; drug-induced<br />

SCLE JAAD 21:343–346, 1989; J Dermatol 15:76–82, 1988;<br />

exacerbation of lupus erythematosus Cutis 17:361–363, 1976<br />

Hydantoin – pellagrous dermatitis JAAD 46:597–599, 2002<br />

Hydroxychloroquine Ann DV 128:729–731, 2001<br />

Hydrochlorthiazide – drug-induced SCLE Ann Intern Med<br />

103:49–51, 1985<br />

Hydroxyurea JAAD 36:178–182, 1997; hydroxyurea-associated<br />

squamous dysplasia – photodistributed red scaly patches<br />

JAAD 51:293–300, 2004<br />

Ibuprofen – UVA JAAD 26:114–116, 1992<br />

Imipramine – brown, slate-gray, or purple hyperpigmentation<br />

JAAD 40:159–166, 1999; JAMA 254:357–358, 1985<br />

Indomethacin, topical BJD 90:91–93, 1974<br />

Interferon-α and ribavirin BJD 147:1142–1146, 2002<br />

Interferon-β – drug-induced SCLE Lancet 352:1825–1826, 1998<br />

Isoniazid – photo-lichenoid eruption Photodermatol<br />

Photoimmunol Photomed 14:77–78, 1998; pellagrous dermatitis<br />

JAAD 46:597–599, 2002<br />

Isotretinoin – UVA/?UVB<br />

Itraconazole – photodermatitis and retinoid-like dermatitis<br />

J Eur Acad Dermatol Venereol 14:501–503, 2000; J Eur Acad<br />

DV 14:444, 2000<br />

Ketoconazole Clin Exp Dermatol 13:54, 1988<br />

Ketoprofen – UVA, photocontact dermatitis Am J Contact<br />

Dermatitis 12:180–181, 2001; Contact Dermatitis 43:16–19,<br />

2000; prolonged photosensitivity Dermatology 201:171–174,<br />

2000<br />

Lichen planus-like photoeruptions JAAD 33:551–73, 1995<br />

Chloroquine<br />

Demeclocycline<br />

Enalapril<br />

Ethambutol JAAD 33:675–676, 1995<br />

Hydrochlorthiazide – UVA<br />

Hydroxychloroquine<br />

Quinidine<br />

Quinine<br />

Sulfonamides<br />

Sulfonylureas<br />

Tiopronin JAAD 31:66–67, 1994<br />

Lupus erythematosus – drug-induced lupus erythematosus –<br />

phenytoin, cimetidine, oral contraceptives, hydralazine,<br />

methyldopa, penicillins, procainamide, sulfonamides,<br />

tetracycline, thiouracil, tiopronin, trimethadone Ghatan p.232,<br />

2002, Second Edition; JAAD 31:665–667, 1994; drug-induced<br />

subacute cutaneous LE – photodistributed erythema, annular<br />

scaly lesions – α-methyl dopa, carbamazepine<br />

AD 141:103–104, 2005; chlorpromazine, cotrimoxazole,<br />

phenytoin, ethosuximide, gold salts, isoniazide, lithium,<br />

methylthiouracil, minocin, naproxen JAMA 268:51–52, 1992;<br />

oral contraceptives, para-amino salicylic acid, penicillin,<br />

penicillamine, phenylbutazone, phenylethylacetylurea, practolol,<br />

propylthiouracil, quinidine, reserpine, rifampin Clin Exp<br />

Dermatol 26:260–262, 2001; streptomycin, sulfasalazine,<br />

sulfonamides, terbinafine BJD 139:1132–1133, 1998;<br />

tetracycline, trimethadone Ghatan p.233, 2002, Second Edition;<br />

pravastatin, simvastatin, hydrochlorthiazide, enalapril, lisinopril,<br />

diltiazem, nifedipine, interferon-α, griseofulvin, oxprenolol,<br />

procainamide, etanercept, infliximab AD 139:45–49, 2003;<br />

Lancet 359:579–580, 2002<br />

Melofenamic acid – UVA<br />

6-mercaptopurine<br />

Mesalazine Am J Gastroenterol 94:3386–3387, 1999<br />

Methotrexate photorecall Cutis 66:379–382, 2000;<br />

JAAD 40:367–398, 1999; Photodermatol Photoimmunol<br />

Photomed 11:55–56, 1995; AD 117:310–311, 1981;<br />

Arch Int Med 115:285–293, 1965<br />

Methyldopa AD 124:326–327, 1988<br />

Methylene blue Pediatrics 97:717–721, 1996<br />

Minoxidil – UVA<br />

Nabumetone – UVA; pseudo-PCT J Rheumatol 27:1817–1818,<br />

2000; JAAD 40:492–493, 1999<br />

Nalidixic acid – UVA Photochem Photobiol 39:57–61, 1984;<br />

bullous photoreaction Am J Med 58:576–580, 1975; BJD<br />

91:523–528, 1974<br />

Naproxen – UVA – pseudoporphyria Scand J Rheumatol<br />

24:108–111, 1995; drug-induced SCLE JAAD 35:147–169, 1996<br />

Nicotinamide<br />

Nifedipine – UVB JAAD 38:201–206, 1998; photodistributed<br />

facial telangiectasia BJD 129:630–633, 1993; <strong>Dermatologic</strong>a<br />

182:196–198, 1991; drug-induced SCLE Hum Pathol 28:67–73,<br />

1997<br />

Oral contraceptives Am Fam Physician 4:68–74, 1971; Med<br />

Ann Dist Columbia 40:501–503, 1971; Obstet Gynecol Surv<br />

25:389–401, 1970; AD 101:181–186, 1970; BJD 81:946–949,<br />

1969; JAMA 203:980–981, 1968<br />

Oxaprozin – pseudoporphyria AD 132:1519–1520, 1996

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!